Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hilary-Kay Young is active.

Publication


Featured researches published by Hilary-Kay Young.


Transactions of The Royal Society of Tropical Medicine and Hygiene | 1989

Antibiotic resistance in the tropics 1. The genetics of bacterial ampicillin resistance in tropical areas

Hilary-Kay Young; L. Sarada Nandivada; S. G. B. Amyes

Ampicillin and its derivatives are the most widely used beta-lactam antibiotics throughout the world. Ampicillin resistance in Gram-negative bacteria is usually manifested by plasmid-encoded beta-lactamases, which hydrolyse the beta-lactam ring of the antibiotic. There are at least 30 different plasmid-encoded beta-lactamases but almost all of them are found very infrequently. The one exception is the TEM-1 beta-lactamase which is found wherever transferable ampicillin resistance emerges and accounts for over 50% of all plasmid encoded ampicillin resistance. In India, the incidence of ampicillin resistance is high (82%) and, amongst Escherichia coli, a significant proportion of the plasmid-encoded beta-lactamases are different from those found in the United Kingdom. Although many Gram-negative species are able to accept the TEM-1 beta-lactamase, certain species have a pre-disposition to their own plasmid beta-lactamase types.


European Journal of Clinical Microbiology & Infectious Diseases | 1990

Detection in the UK of trimethoprim-resistantEscherichia coli encoding the type V dihydrofolate reductase

K. J. Towner; Hilary-Kay Young; C. J. Thomson; S. G. B. Amyes

Seven major types of trimethoprim-resistant dihydrofolate reductases (DHFRs) coded for by plasmids in gram-negative bacteria have now been described, with several of these major groups being further divided into related subtypes (1). Of the seven major types, the type V DHFR was originally identified in clinical isolates of enterobacteria from Sri Lanka (2) and has not been reported to occur in Europe. We have previously described a DNA probe suitable for monitoring the spread of plasmids mediating this form of trimethoprim resistance (3). This probe was used in a retrospective study to examine 14 trimethoprim R plasmids originally isolated during the period 1980-82 as part of an investigation into the distribution of the DHFR type I gene in the Nottingham area of the UK (4). The 14 trimethoprim R plasmids selected (Table 1) were those that had previously been found not to show any hybridisation with the DNA probe for the predominant type I gene (4).


Epidemiology and Infection | 1991

Detection of novel trimethoprim resistance determinants in the United Kingdom using biotin-labelled DNA probes.

K. J. Towner; G. I. Carter; Hilary-Kay Young; S. G. B. Amyes

Two collections of trimethoprim R plasmids, isolated from strains of Escherichia coli during 1978-83 and 1987-8 respectively, were retrospectively screened with specific biotinylated DNA probes for the presence of genes encoding particular DHFR enzymes. The results confirmed that the type I DHFR gene was the predominant plasmid-encoded gene conferring trimethoprim resistance in strains of E. coli from the Nottingham area of the UK, but indicated that genes encoding the more recently recognized types of DHFR enzymes had appeared in the bacterial gene pool and could be recognized with increased frequency in the latter plasmid collection. This was particularly true of the type IIIa and type VII enzymes which together accounted for 27% of the trimethoprim R plasmids examined in 1987-8.


Journal of Antimicrobial Chemotherapy | 1999

Identification and characterization of class 1 integrons in bacteria from an aquatic environment

Susan J. Rosser; Hilary-Kay Young


Clinical Microbiology and Infection | 2005

Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina

Hilary-Kay Young; S. G. B. Amyes


Journal of Antimicrobial Chemotherapy | 1993

Antimicrobial resistance spread in aquatic environments

Hilary-Kay Young


The Lancet | 1998

Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2

Carlos Bantar; Hilary-Kay Young; S. G. B. Amyes


Journal of Antimicrobial Chemotherapy | 1986

Trimethoprim resistance amongst urinary pathogens in South India

Hilary-Kay Young; Mary V. Jesudason; Grace Koshi; S. G. B. Amyes


Journal of Antimicrobial Chemotherapy | 1994

Nucleotide sequence and genetic analysis of the type Ib trimethoprim-resistant, Tn4132-encoded dihydrofolate reductase

Hilary-Kay Young; M. J. Qumsieh; M. Louise Mclntosh


Journal of Antimicrobial Chemotherapy | 1989

The type VII dihydrofolate redactase: a novel plasmid-encoded trimetfaoprim-resistaiit enzyme from Gram-negative bacteria isolated in Britain

S. G. B. Amyes; K. J. Towner; G. L. Carter; C. J. Thomson; Hilary-Kay Young

Collaboration


Dive into the Hilary-Kay Young's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

B. A. Wylie

University of the Witwatersrand

View shared research outputs
Top Co-Authors

Avatar

Hendrik J. Koornhof

University of the Witwatersrand

View shared research outputs
Researchain Logo
Decentralizing Knowledge